Jiating Chen
Shenzhen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Photodynamic Therapy for Toxoplasma gondii Infections Using Rose Bengal.
Journal: Luminescence : the journal of biological and chemical luminescence
Published: March 03, 2026
An AIE photosensitizer with type I/II ROS generation for photodynamic therapy of toxoplasmosis.
Journal: Chemical communications (Cambridge, England)
Published: January 06, 2026
Reshaping the therapeutic landscape of IgA nephropathy: a Bayesian network meta-analysis on the comparative efficacy and safety of immunosuppressants and targeted agents.
Journal: BMC nephrology
Published: December 19, 2025
Divergent Renal Benefits of Sodium-Glucose Cotransporter-2 Inhibitors and Mineralocorticoid Receptor Antagonists in Nondiabetic Kidney Disease.
Journal: Kidney & blood pressure research
Published: December 01, 2025
PM2.5-induced oxidative stress upregulates PLA2R expression in the lung and is involved in the pathogenesis of membranous nephropathy through extracellular vesicles.
Journal: Frontiers in pharmacology
Published: October 23, 2024
Pathological mechanisms of glial cell activation and neurodegenerative and neuropsychiatric disorders caused by Toxoplasma gondii infection.
Journal: Frontiers in microbiology
Published: October 16, 2024
Toxoplasma gondii bradyzoite-specific BAG1 is nonessential for cyst formation due to compensation by other heat-shock proteins.
Journal: Parasites & vectors
Published: March 29, 2024
Toxoplasma gondii gra5 deletion mutant protects hosts against Toxoplasma gondii infection and breast tumors.
Journal: Frontiers in immunology
Published: February 24, 2023
Toxoplasma gondii infection possibly reverses host immunosuppression to restrain tumor growth.
Journal: Frontiers in cellular and infection microbiology
Published: June 01, 2022
Toxoplasma gondii DNA methyltransferases regulate parasitic energy metabolism.
Journal: Acta tropica
Published: October 19, 2021
Toxoplasma gondii Type-I ROP18 Targeting Human E3 Ligase TRIM21 for Immune Escape.
Journal: Frontiers in cell and developmental biology
Published: March 26, 2021
Showing 1-12 of 12
Last Updated: 09/26/2026